Page last updated: 2024-12-08

n-demethyltramadol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-demethyltramadol: one of the major metabolites of tramadol; structure given in first source; RN given refers to parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID198555
CHEBI ID172338
SCHEMBL ID4393890
MeSH IDM0215261

Synonyms (25)

Synonym
73806-55-0
CHEBI:172338
1-(3-methoxyphenyl)-2-(methylaminomethyl)cyclohexan-1-ol
n-desmethyltramadol
n-demethyltramadol
cyclohexanol, 1-(m-methoxyphenyl)-2-methylaminomethyl-
brn 2853536
1-(m-methoxyphenyl)-2-methylaminomethylcyclohexanol
FT-0666237
FT-0666236
FT-0666234
AKOS015962246
(+/-)-n-desmethyl tramadol
SCHEMBL4393890
VUMQHLSPUAFKKK-UHFFFAOYSA-N
1018989-94-0
cyclohexanol, 1-(3-methoxyphenyl)-2-[(methylamino)methyl]-
n-demethyl tramadol
1-(3-methoxyphenyl)-2-((methylamino)methyl)cyclohexanol
DTXSID50891485
CS-0259500
1-(3-methoxyphenyl)-2-[(methylamino)methyl]cyclohexan-1-ol
EN300-7352624
metabolite of tramadol
Z3234967353

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" A simultaneous pharmacokinetic model describing the plasma concentration-curves of the generated metabolites and the parent compounds after intravenous and oral drug administration is developed and presented."( Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
Azanza, JR; Campanero, MA; Cardenas, E; García Quetglas, E; Sádaba, B, 2007
)
0.34
" The related pharmacokinetic parameters such as C(max), T(max), AUC((0-t)), AUC((0-infinity)), T(1/2) and Cl/F were calculated and compared between the two genders."( Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers.
Ardakani, YH; Rouini, MR, 2007
)
0.34
" The findings suggest that the SR formulation of tramadol may not have suitable pharmacokinetic characteristics to be administered once-a-day as an effective and safe treatment for pain in the dog."( Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study.
Giorgi, M; Kowalski, C; Lebkowska-Wieruszewska, B; Saccomanni, G, 2009
)
0.35
" The method developed and validated here was applied to a pharmacokinetic study in rats."( Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.
Carvalho, TM; De Moraes, NV; Godoy, AL; Lanchote, VL; Marques, MP; Martinez, EZ, 2011
)
0.37
"The serum pharmacokinetic profile and urinary excretion of tramadol and its metabolites (O-desmethyltramadol [M1], N-desmethyltramadol [M2] and N,O-desmethyltramadol [M5]) was investigated in a multidrug anaesthetic and analgesic approach for orchiectomy in horses."( Clinical pharmacokinetics of tramadol and main metabolites in horses undergoing orchiectomy.
Cagnardi, P; Ferraresi, C; Pecile, A; Ravasio, G; Villa, R; Zani, DD; Zonca, A, 2014
)
0.4
" There was not a significant difference in the elimination half-life between age groups (1."( Effects of age on the pharmacokinetics of tramadol and its active metabolite, O-desmethyltramadol following intravenous administration to foals.
Knych, HK; McKemie, DS; Steffey, EP; White, AM, 2016
)
0.43
" This study describes the pharmacokinetic profile of tramadol when a single subcutaneous bolus of 2 mg/kg was initially administered to two koalas."( Pharmacokinetic profile of injectable tramadol in the koala (Phascolarctos cinereus) and prediction of its analgesic efficacy.
Govendir, M; Kimble, B; Valtchev, P; Vogelnest, L, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's6 (23.08)29.6817
2010's16 (61.54)24.3611
2020's3 (11.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.92 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (19.23%)5.53%
Reviews1 (3.85%)6.00%
Case Studies3 (11.54%)4.05%
Observational0 (0.00%)0.25%
Other17 (65.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]